Cargando…
The Use of Low-Dose Intermittent Levosimendan Infusion Therapy as Bridge-to-Left Ventricular Assist Device in Advanced Chronic Heart Failure Secondary to Isolated Cardiac Sarcoidosis
Heart failure (HF) is a progressive condition that usually involves a debilitating late course with poor health-related quality of life and increasing mortality rate. In this report, we demonstrate the efficacy and safety of intermittent levosimendan infusion as a bridging therapy to left ventricula...
Autores principales: | Al-Wahaibi, Kamla, Elfadil, Osman Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104322/ https://www.ncbi.nlm.nih.gov/pubmed/33986931 http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_85_20 |
Ejemplares similares
-
Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
por: Segev, Amitai, et al.
Publicado: (2022) -
Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
por: Abdelshafy, Mahmoud, et al.
Publicado: (2022) -
Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation
por: Sugimura, Yukiharu, et al.
Publicado: (2023) -
Intermittent levosimendan infusions in advanced heart failure: a real world experience
por: Ortis, Benedetta, et al.
Publicado: (2017) -
Bridge to Transplantation with a Left Ventricular Assist Device
por: Jung, Jae Jun, et al.
Publicado: (2012)